MOUNTAIN VIEW, Calif., July 31 /PRNewswire/ -- Cardiva Medical, Inc., a
privately held medical device company, announced today that Augustine Lien,
Chairman and CEO, will present at the BMO Capital Markets 2008 Focus on
Healthcare conference on Tuesday, August 5 at 1:15 p.m. EDT at the
Millennium Broadway Hotel in New York City. Mr. Lien's presentation will
include an overview of the Company's current operations and growth
Details of the presentation follow:
Date: Tuesday, August 5, 2008
Time: 1:15 p.m. (EDT)
Location: The Millennium Broadway Hotel
Speaker: Augustine Lien, Chairman and CEO
About Cardiva Medical, Inc.
Founded in July 2002, and headquartered in Mountain View, Calif., Cardiva Medical, Inc. is a privately held medical device company focused on developing and commercializing devices which close the vascular access site with unsurpassed safety and ease-of-use. Cardiva's first product, the Boomerang Wire System, was approved in EU countries and in the U.S. in 2004. Cardiva's second-generation product, the Boomerang Catalyst System, was approved in March 2007 and launched in July 2007. The enhanced Boomerang Catalyst, trade named as "Boomerang Catalyst II System" received 510(K) clearance in September 2007 and launched in January 2008. To date, the family of Boomerang and Boomerang Catalyst devices has been used in 150,000 percutaneous catheterization procedures in the U.S. Cardiva was selected by Frost & Sullivan as the recipient of the 2006 Frost & Sullivan Award for Entrepreneurial Company in the U.S. angioplasty and vascular closure devices market. For additional information about Cardiva please see our website at http://www.cardivamedical.com.
Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimated" and "intend," among
others. These forward-looking statements are based on Cardiva's current
expectations and actual results could differ materially. Cardiva does not
undertake an obligation to update or revise any forward-looking statement.
Cardiva, Boomerang and Boomerang Catalyst System are trademarks/registered
trademarks of Cardiva Medical, Inc.
Glenn Foy, President
Cardiva Medical, Inc.
|SOURCE Cardiva Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved